Living One Day Longer Than My Father

January 18th 2021, 5:00pm

By Khevin Barnes

As a cancer survivor, I’ve found many reasons to celebrate. Here’s one more.

For Younger Patients, CAR T-Cell Therapy Could Play a Role in CLL Treatment

January 18th 2021, 4:00pm

By Jessica Skarzynski

In an interview, Dr. Matthew Davids of the Dana-Farber Cancer Institute discusses the future of CAR T-Cell therapy in the treatment of younger patients with chronic lymphocytic leukemia.

In Cancer Caregiving, a Passion for Learning is Vital

January 18th 2021, 2:00pm

By Jessica Skarzynski

Caregiving for a patient with cancer is an ongoing journey that also requires the caregiver to learn along the way. One couple discusses that process and more.

Count Me Among The Breast Cancer Recurrence Project

January 17th 2021, 7:00pm

By Martha Carlson

The Breast Cancer Recurrence Project aims to revolutionize and bring accuracy to what we know about who’s living with metastatic breast cancer.

Counseling, Targeted Interventions Needed to Improve Health-Related Quality of Life in Young Colon Cancer Survivors

January 17th 2021, 3:00pm

By Conor Killmurray

The researchers concluded that the overall low health-related quality of life scores for young CRC survivors in the categories of social and functional well-being should be targeted by appropriate methods, which could include counseling and quality of life interventions.

Celebrating A ‘Cancerversary’ In A COVID-19 World

January 16th 2021, 8:00pm

By Kelly Irvin

It’s okay for me to not feel like celebrating my 5-year cancerversary in a world that is upside down and backward because of COVID-19. Yes, I’m grateful and blessed, but I’m not bullet-proof. I’m human. I don’t have to feel guilty. None of us do.

Alleviating Pandemic-Related Anxiety Over Returning to the Clinic for Clinical Trials

January 16th 2021, 2:00pm

In an interview with CURE®, expert Martha Raymond explains the importance of clinical trials during the COVID-19 pandemic and how clinicians must find a way to help ease patients anxieties as they return to the clinic.

Areas Patients with CLL Can Focus On to Maintain Their Health Beyond Treatment

January 15th 2021, 10:00pm

By Jessica Skarzynski

In a recent interview with CURE®, a medical oncologist from the Dana-Farber Cancer Institute discussed why it’s important for patients with CLL, regardless of their treatment plans, to keep up on vaccinations and maintain a regular cancer screening schedule.

Enhertu Receives FDA Approval for Gastroesophageal, Gastric Cancer Subset

January 15th 2021, 9:44pm

By Ryan McDonald

The Food and Drug Administration approved Enhertu to treat adults with locally advanced or metastatic HER2-positive gastroesophageal or gastric cancer who have previously received a trastuzumab-based treatment regimen.

Communication is Key When Navigating Cancer and a Marriage

January 15th 2021, 2:00pm

By Jessica Skarzynski

Janice and Rex Cowden sat down for an interview to discuss how to navigate a cancer diagnosis as a couple, and that communication is not only the key to a better cancer journey but a better marriage.

FDA Approves Xalkori for Children, Young Adults With Relapsed or Refractory Anaplastic Large Cell Lymphoma

January 14th 2021, 10:49pm

By Ryan McDonald

The Food and Drug Administration approved the supplemental new drug application for Xalkori (crizotinib) to treat children and young adults between the ages of 1 and 21 with relapsed or refractory, systemic ALK-positive anaplastic large cell lymphoma.

Living in Low-Income, Rural Households Associated With Greater Risk of Death for Patients With Liver Cancer

January 14th 2021, 10:30pm

By Colleen Moretti

Patients with hepatocellular carcinoma who live in low-income and rural households are less likely to receive high quality care and therefore are more likely to be diagnosed with an advanced stage cancer.

Triple Therapy with Darzalex Improves Pain, Quality of Life in Newly Diagnosed Multiple Myeloma Ineligible for Stem Cell Transplantation

January 14th 2021, 8:00pm

By Darlene Dobkowski, MA

Quality of life improved in patients treated with Darzalex, Revlimid and dexamethasone compared with Revlimid and dexamethasone, and were present regardless of age, functional status and the depth of their treatment response.

Risky Business: Navigating COVID Challenges To Still Find Connection

January 14th 2021, 5:00pm

By Steve Rubin

A survivor discusses the challenges of finding connections during COVID-19.

Adding Copiktra to Standard of Care Chemotherapy Combination in CLL Could Improve Outcomes, But Not Without Toxicities

January 14th 2021, 3:00pm

By Jessica Skarzynski

In a recent interview with CURE®, a medical oncologist from the Dana-Farber Cancer Institute in Boston discussed how the addition of Copiktra to a three-drug chemotherapy combination improved outcomes in patients with CLL, with more than half achieving complete remission.